Le Lézard
Classified in: Health

FDAnews Announces -- Secure and Accelerate Product Approvals: Reap the Rewards of FDA's Breakthrough Designations Webinar, July 30, 2019


FALLS CHURCH, Va., July 23, 2019 /PRNewswire-PRWeb/ -- Secure and Accelerate Product Approvals
Reap the Rewards of FDA's Breakthrough Designations
**An FDAnews Webinar**
Tuesday, July 30, 2019, 1:30-3:00 p.m. EDT
https://www.fdanews.com/productapprovals

Take advantage of the expedited FDA approval programs for drugs and devices. Understand what it takes to qualify and how to secure the benefits to make a big difference in the bottom line.

Join FDA legal experts Greg Levine, Esq. and Kelly Combs, Esq. as they clarify it all. Both are partners in the life sciences practice group at Ropes & Gray LLP, with Mr. Levine as co-chair.

Attendees will learn the various programs' unique eligibility criteria, distinctive benefits and when to pursue each in the product-development timeline to reap potentially significant rewards.

This webinar will help attendees and team members:

Expedited approval programs for drugs and biologics, including highlights from the 2014 FDA guidance

Breakthrough devices program, including highlights from the 2018 guidance

Hypotheticals and real-world examples regarding eligibility for expedited programs

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

Webinar Details:
Secure and Accelerate Product Approvals
Reap the Rewards of FDA's Breakthrough Designations
**An FDAnews Webinar**
Tuesday, July 30, 2019, 1:30-3:00 p.m. EDT
https://www.fdanews.com/productapprovals

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/productapprovals
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

 

SOURCE FDAnews


These press releases may also interest you

at 11:13
CQ Medical, the new global leader in patient radiotherapy positioning and healthcare innovations that advance human care, will exhibit its innovative and patented solutions during the annual ESTRO Congress in Glasgow, United Kingdom, from 3 to 6 May...

at 11:03
Marpai, Inc. ("Marpai" or the "Company") , an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced...

at 11:00
Today, Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for VELSIPITYtm. A once-daily oral treatment, VELSIPITY is for adult patients with moderately to severely active ulcerative colitis (UC) who have had an...

at 11:00
Manna Tree, a global private equity firm committed to improving human health through nutrition, today announced the strategic additions of Adam Whitehead as Director of Investor Relations and Attie Hoffman as Vice President of Strategic...

at 11:00
Innovative Community Oncology Practices (ICOP) is proud to announce its endorsement of Oncentric as the preferred healthcare technology and services provider for all its member practices. This partnership aims to improve health outcomes and enhance...

at 11:00
Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showing the performance of its Mercy Halotm...



News published on and distributed by: